# Per-operating Use of a Probe for Detection of β+

> **NCT02666599** · NA · TERMINATED · sponsor: **University of Lausanne Hospitals** · enrollment: 5 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **RADIATION:** 18F-FDG PET/CT

## Key facts

- **NCT ID:** NCT02666599
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-30
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02666599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02666599, "Per-operating Use of a Probe for Detection of β+". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02666599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*